FDA-Issued Kratom Recall Highlights AJPB Week in Review


Top news of the week from The American Journal of Pharmacy Benefits.

5. FDA Issues Refusal to File Letter for Major Depressive Disorder Drug

The FDA issued a Refusal to File letter regarding its new drug application for ALKS 5461 for adjunctive treatment of major depressive disorder in patients with an inadequate response to standard antidepressant therapies. Read more.

4. Antibiotics May Increase Heart Disease Risk in Older Women

Women who take antibiotics for long periods, especially in late adulthood, have an increased risk of death from heart disease and in general. Read more.

3. FDA Expands Bydureon Indication in Type 2 Diabetes

The FDA approved an expanded indication for exenatide extended-release (Bydureon) for its use as an add-on therapy to basal insulin in adults with type 2 diabetes with inadequate glycemic control, announced AstraZeneca. Read more.

2. Drug Combo Improves Activity in Heart Failure Patients

Treatment with sacubitril/valsartan (Entresto) improved several types of physical and social activities in heart failure patients with reduced ejection fraction compared with enalapril. Read more.

1. FDA Issues Kratom Recall Over Salmonella

In a first-time issuance under the Food Safety Modernization Act, the FDA has announced a mandatory recall order for all food products containing powdered kratom that were manufactured, processed, packed, or held by Triangle Pharmanaturals LLC. Read more.

Related Videos
Whole psilocybin mushroom in a clear medication capsule | Image credit: Zim - stock.adobe.com
Patient suffering from atopic dermatitis -- Image credit: Nikkikii | stock.adobe.com
Image credit: Fabio Balbi | stock.adobe.com
Image credit: Melita - stock.adobe.com
Video 6 - "Stakeholder Perspective: Step-Up Dosing for Bispecific Antibodies in Multiple Myeloma"
Emergency CPR on a Man who has Heart Attack , One Part of the Process Resuscitation (First Aid) - Image credit: Platoo Studio | stock.adobe.com
Atopic dermatitis on a patient's hand -- Image credit: Ольга Тернавская | stock.adobe.com
© 2024 MJH Life Sciences

All rights reserved.